VCEL Q1 2017 Earnings — Vericel Corporation Revenue & Financial Results | Market Cap Arena

VCELVericel Corporation

$2B

Q1 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$9M-33.6% YoY

Gross Profit

$2M24.1% margin

Operating Income

-$10M-102.8% margin

Net Income

-$10M-104.5% margin

EPS (Diluted)

$-0.31

QoQ Revenue Growth

-43.3%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$3M

Stock-Based Comp.

$502,000

Balance Sheet

Total Assets

$41M

Total Liabilities

$25M

Stockholders' Equity

$16M

Cash & Equivalents

$20M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$9M	$14M	-33.6%
Gross Profit	$2M	$8M	-70.2%
Operating Income	-$10M	-$2M	-383.1%
Net Income	-$10M	-$4M	-167.9%